相关实验视频

Updated: Jul 1, 2025

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

合理设计的新型AAV囊用于关节内基因传递

Wenjun Li^1,2, Susi Liu Feng¹, Lizette Herrschaft¹

¹Gene Therapy Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.

Molecular therapy. Methods & clinical development

|March 4, 2024

概括

新型腺相关病毒 (AAV) 基因治疗载体在小鼠中显示加强了关节转导. 改造的AAV突变物提高了疗效,减少了目标外影响,为治疗关节疾病提供了潜力.

科学领域:

基因治疗是一种基因疗法.
整形外科整形外科整形外科
病毒学病毒学

背景情况:

关节内腺相关病毒 (AAV) 基因疗法对关节疾病具有前景.
挑战包括低转导效率,非目标表达和中和抗体 (Nabs).

研究的目的:

选AAV血清型,以获得最佳的关节转导.
为改进关节内基因传递设计新型AAV囊.
研究特定氨基酸修饰对AAV转导和免疫性的影响.

主要方法:

选的AAV血清型1-9用于小鼠的关节内关节转导.
设计的新型AAV囊体,包括AAV62 (AAV2 VRI交换成AAV6).
产生和测试了AAV6D (T265删除) 和AAV6M (A263突变) 突变.

主要成果:

在查的血清型中,AAV6表现出最高的关节转导率.
AAV62显示每个基因组拷贝数的转导效率增加.
与AAV6.6相比,AAV6D的转导率增加了2倍.
在AAV6M中,转导率下降了10倍.
AAV6D有效地转化了突细胞和突细胞,最小的脱转化和减少了Nab的形成.

结论:

合理工程的AAV囊可以增强关节内关节管理后的关节转导.
像AAV6D这样的新型AAV突变体显示出改善关节疾病的基因治疗的潜力.
设计的AAV载体可能会逃避NABS,并最大限度地减少肝脏的非目标效应.

关键词:

在 AAV AAV AAV 中.没有了,没有了,没有了.工程工程工程工程工程共同的共同的共同的共同的合理的设计理性的设计.转导是指一个转导的过程.

更多相关视频

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Production, Purification, and Quality Control for Adeno-associated Virus-based Vectors

Published on: January 29, 2019

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Engineering and Evolution of Synthetic Adeno-Associated Virus AAV Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...